About Us
Visual inspection expertise, built into software
InQuest Science is the only digital defect management solution built by authors of USP <790> and <1790>, the chapters that govern pharmaceutical visual inspection. That expertise is built into Identifier, which unites particulate and defect data across the entire product lifecycle, from raw materials to finished product, giving quality teams one source of truth in place of scattered spreadsheets and disconnected databases.
Purpose
InQuest Science LLC was established to develop and provide particulate matter, product defect trending and life cycle data management solutions for the Pharmaceutical, Medical Device and Health Care Industries.
Our Mission
Provide the Pharmaceutical, Medical Device, and Health Care Industries a modern electronic approach to process defect data management, and facilitate evaluation of each product batch before distribution to patients.
Distinction
Identifier serves pharmaceutical manufacturers, CMOs, CROs, defect standards producers, and particulate ID labs, replacing spreadsheets with one validated database.
Our Team
Anthony Amato
Chief Executive Officer
Mr. Amato founded InQuest Science in March of 2017. He founded Amega Scientific Corporation in 1999. He grew the company from a startup operation to a worldwide industry leader.
Roy Cherris
Chief Science Officer
Mr. Cherris has over 40 years of Quality Assurance experience and is a founding member and Managing Partner of Bridge Associates International. An author of USP <790> and <1790> and an active member of the USP expert panel, he is one of the industry’s foremost authorities on visual inspection.
Jeff Marino
Chief Technology Officer
Mr Marino runs a successful software consultancy, BaSys Tech Services. He began his career in the pharmaceutical industry in 1993 building vision and barcode inspection systems.
Maggie Schwanda
Director of Business Operations
Ms. Schwanda was the Director of Business Operations for Amega Scientific Corporation. She was responsible for the groups global business development.
Anthony Amato II
Product Development Manager
Mr. Amato is responsible for the organization strategies through the effective direction and management of resources, while being accountable for the business strategies.
Michael Winton
Advisor
Mr. Winton is a private equity professional and middle market CFO with more than 12 years of finance, investment banking, and corporate strategy experience in the manufacturing, services, and financial industries.
In memoriam
Scott Aldrich
Scientific Advisor
Mr. Aldrich worked in the pharmaceutical industry for over forty years and was an author of USP <790> and <1790>. His expertise centered on the application of materials science methods for the identification of particulate matter.
Our Commitment
Behind every injectable drug is a patient who trusts it is safe. InQuest Science exists to help the companies who make those medicines honor that trust, giving quality teams a modern way to detect defects, qualify inspectors, and prove compliance with confidence.
Our goal is simple: to set the new standard for particulate and defect data management, so that safer products reach the people who depend on them.
See Identifier
Tell us about your inspection program and the InQuest Science team will set up a demo.